american

Myriad Genetics RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

SALT LAKE CITY, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic…

3 days ago

NORTH AMERICAN MANUFACTURERS BEGIN STOCKPILING TO BUFFER AGAINST TARIFFS WHILE ASIAN SUPPLIERS RECORD RENEWED GROWTH AS CHINESE MANUFACTURING REBOUNDS, DRIVEN BY STIMULUS AND EXPORTS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Increased safety stockpiling reported by North American manufacturers, led by the U.S., as firms anticipate higher imported costsAsian factories' purchasing…

6 days ago

NORTH AMERICAN MANUFACTURERS BEGIN STOCKPILING TO BUFFER AGAINST TARIFFS WHILE ASIAN SUPPLIERS RECORD RENEWED GROWTH AS CHINESE MANUFACTURING REBOUNDS, DRIVEN BY STIMULUS AND EXPORTS: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX

Increased safety stockpiling reported by North American manufacturers, led by the U.S., as firms anticipate higher imported costsAsian factories' purchasing…

6 days ago

COVID Non-pharmaceutical Interventions Were Harmful Authoritarian Overreach, according to Journal of American Physicians and Surgeons

TUSCON, Ariz., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Historically, the apocalyptic chaos that accompanied plagues provided evildoers with opportunities for…

2 weeks ago

Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting

December 09, 2024 12:05 ET | Source: Tessera Therapeutics In vivo proof-of-concept achieved in humanized mice and non-human primates (NHPs)…

2 weeks ago

Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

December 09, 2024 12:00 ET | Source: Disc Medicine Inc  Positive updates across all programs, including updates from ongoing clinical…

2 weeks ago

Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting

Poster presentation at ASH on Monday, December 9 at 6:00 p.m. PT / 9:00 p.m. ET CAMBRIDGE, Mass., Dec. 09,…

2 weeks ago

CRISPR Therapeutics Presents Data atthe 2024 American Society of Hematology (ASH) Annual Meeting

December 09, 2024 12:00 ET | Source: CRISPR Therapeutics AG -Preliminary data demonstrate that CTX112™ has the potential to provide…

2 weeks ago

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest…

2 weeks ago

Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting

December 07, 2024 12:00 ET | Source: Y-mAbs Therapeutics, Inc. NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics,…

2 weeks ago
Show more Posts